Caladrius_Logo_March_2017.png
NeoStem Announces the Addition of Jonathan Sackner-Bernstein, MD, Past FDA Official, as Vice President, Clinical Development and Regulatory Affairs
April 11, 2012 09:15 ET | Caladrius Biosciences, Inc.
NEW YORK, April 11, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or "the Company"), a leader in the cell therapy industry, is pleased to announce that Jonathan Sackner-Bernstein,...
Caladrius_Logo_March_2017.png
NeoStem Closes Public Offering for $6,800,000 in Gross Proceeds
April 05, 2012 07:30 ET | Caladrius Biosciences, Inc.
NEW YORK, April 5, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or "the Company"), a leader in the cell therapy industry, announced today the closing of its previously announced...
Caladrius_Logo_March_2017.png
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
March 29, 2012 09:11 ET | Caladrius Biosciences, Inc.
NEW YORK, March 29, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or "the Company"), a leader in the cell therapy industry, announced today the pricing of an underwritten public...
Caladrius_Logo_March_2017.png
NeoStem Announces Proposed Public Offering of Common Stock and Warrants
March 28, 2012 20:21 ET | Caladrius Biosciences, Inc.
NEW YORK, March 28, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or "the Company"), a leader in the cell therapy industry, today announced that it intends to offer and sell shares...
Caladrius_Logo_March_2017.png
NeoStem Provides Updates and Reports Year End Results
March 20, 2012 09:04 ET | Caladrius Biosciences, Inc.
NEW YORK, March 20, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or "the Company") is a leader in the cell therapy industry, developing cell based therapeutics supported by the...
Caladrius_Logo_March_2017.png
NeoStem Announces Participation in Two March Conferences
March 02, 2012 07:00 ET | Caladrius Biosciences, Inc.
NEW YORK, March 2, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), announced today that the Company has been invited to present at two upcoming conferences in...
Caladrius_Logo_March_2017.png
NeoStem Announces Participation in Two February Conferences
February 08, 2012 07:00 ET | Caladrius Biosciences, Inc.
NEW YORK, Feb. 8, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), announced today that the Company and Progenitor Cell Therapy ("PCT"), a NeoStem company, will be...